Therefore, B2-OKT3 BiTE can target MICA on tumor cells and CD3ε on T cells through the tandem scFv BiTE format, which specifically induces T cells to kill tumor cells (Godbersen et al., 2017) (Figure 3). The gene discussed is CD3E; the disease is neoplasm.